Erste Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
Erste Asset Management's AZN Position: Q1 2026 in Review
Erste Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 486,374 shares — an estimated $89.5M sold.
Erste Asset Management first reported a position in AZN in Q4 2020 and held it in 21 quarters. The position peaked at $89.5M in Q4 2025. 1,386 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Erste Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Erste Asset Management sold 486,374 AstraZeneca shares in Q1 2026, an estimated $89.5M.
- Erste Asset Management first reported a position in AstraZeneca in Q4 2020 and held it in 21 quarters.
- Erste Asset Management's AstraZeneca position peaked at $89.5M in Q4 2025.
- 1,386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Erste Asset Management's 13F filing for Q1 2026, filed 11 May 2026.